Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
E Kissling (
)<SUP>1</SUP>, M Valenciano<SUP>1</SUP>, I-MOVE case?control studies team<SUP>2</SUP>
Citation style for this article: Kissling E, Valenciano M, I-MOVE case?control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case?control study, 2011/12. Euro Surveill. 2012;17(15)
ii=20146. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20146
Date of submission: 03 April 2012 <HR>To provide an early estimate of 2011/12 influenza vaccine effectiveness (VE), we conducted a multicentre case?control study based on seven sentinel surveillance networks. We included influenza-like illness cases up to week 7/2012 from the vaccination target groups, swabbed less than eight days after symptom onset. Laboratory-confirmed influenza A(H3) cases were compared to negative controls. Adjusted VE was 43% (95% confidence interval: -0.4 to 67.7), suggesting low to moderate VE against influenza A(H3) in the early 2011/12 season.
- ------
Eurosurveillance, Volume 17, Issue 15, 12 April 2012
Rapid communications
Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case?control study, 2011/12
Rapid communications
Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case?control study, 2011/12
E Kissling (
- EpiConcept, Paris, France
- Members of the team are listed at the end of the article
Citation style for this article: Kissling E, Valenciano M, I-MOVE case?control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case?control study, 2011/12. Euro Surveill. 2012;17(15)
Date of submission: 03 April 2012 <HR>To provide an early estimate of 2011/12 influenza vaccine effectiveness (VE), we conducted a multicentre case?control study based on seven sentinel surveillance networks. We included influenza-like illness cases up to week 7/2012 from the vaccination target groups, swabbed less than eight days after symptom onset. Laboratory-confirmed influenza A(H3) cases were compared to negative controls. Adjusted VE was 43% (95% confidence interval: -0.4 to 67.7), suggesting low to moderate VE against influenza A(H3) in the early 2011/12 season.